The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
WishIKnew, not really condescending, just facts. You’re talking about someone who is unqualified to do a job that has potential to negatively affect share price, or the public image of the company. As an investor I would be keen to see this addressed.
I completely agree and said this ages ago multiple times but got called a de-ramper.
The fact is, if you look at where “Mandy” has come from, it’s assistant to the CEO - basically someone who runs a diary, gate keeps his phone calls, and gets his dry cleaning. She is hardly qualified for the role of this importance at this stage in the company’s growth. Someone needs to be driving the narrative and owning the space, not just waiting until it hits the CEO’s agenda.
I can just see her standing in front of Graham whilst she takes notes and he dictates before asking him if he’d like another coffee. It’s not the way the comms department should be run.
I cannot understand this panic. This company has not changed one bit since Monday when this sell-off began. If anything, the landscape for COVID Testing has just got stronger and stronger. Frence saying new national lockdown, UK saying that it will be in Tier3 by December if they can't get it under control, daily cases rising exponentially per day. NCYT still selling boat loads of tests and developing more. Stop selling your shares you morons.
Approval of test by MHRA?
@rcdm - completely ridiculous statement lol
Synlab exist all over Europe and are just a lab services co. I don't know who is supplying the tests but I know that synlab are a service provider so it is unlikely that they have developed their own tests.
This share is gonna blow today!!! Amazing!
Quite ridiculous that people who yesterday morning were confident that this was going to £40 are now selling in droves. Nothing has changed in the fundamentals of this share/company. It still has a growing order book, it's still printing cash, and still exceeding expectations of govts around the world. It is a hold from me.
Why are these questions being asked at this stage?! They sell the machines and sell each test. Hence deal values are high.
Bodes well for a strong Monday and shows they are doing lots of testing.
Yes finally also in the FT, telegraph, and times.
Also the larger of the machines can process up to 300 tests per day. The smaller is less maybe 150 tests per day. so let’s say an average of 200 tests per day in 150 hospitals? In any case, for those asking how is it £150m worth (it’s actually £250m) Multiply 200 test by 300 machines and what do you get? 60,000 test results PER DAY. Then run that for 6 months you get to £250m pretty easily.
Perhaps too busy releasing huge RNS two at a time to bother with newspapers.
I follow the company and I’m invested since 340p.
Independent only is not an adequate news scoop for this size of company news.
Once a deal is signed, which it obviously has been, then it should be in all the major news streams. See DNA Nudge, synairgen news scoops. They were all over every newspaper and on all major radio news briefings. If you can only manage to get the independent to cover it then you’re lacking in contacts/experience
It shouldn’t be up to Twitter and share chat boards to share absolutely massive news like this from a story featured in a paper who are absolutely desperate for anyone to write anything for them. I’m not deramping the news but the comms manager should be fired for the terrible coverage of this.
Novacyt has obviously just been featured in the independent. Great news. However, this hasn’t been a story ANYWHERE else. The communications department at novacyt is absolutely terrible and out of their depth now. This story should have been featured in all the major newspapers. It’s as big, if not bigger, than all the other deals which have been done and which I’ve seen/heard mentioned on all major news channels and papers. To have it featured only in the independent smacks of a communications manager lacking in contacts or not knowing what they’re doing.
Haha I have reread and makes sense now!
It’s not really about being cheery. It’s about knowing industry contacts for PR opportunities, working intelligently with journalists to control the narrative about the industry developments, making sure that every time there is an article about testing that your company is called for comment. Sorry but she isn’t qualified for the role she is in, especially following the company’s recent growth. This is no longer a joke, this is a serious company that needs a professional and experienced PR operation. Former PA to CEO simply doesn’t cut it now, I’m afraid.
Don’t expect to receive anything revolutionary. This woman is highly unqualified for this role of investor relations and communication if you look at her CV - for a company of this size anyway.